Global Kidney Cancer Treatment Drugs Market 2019 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • This report focuses on the global Kidney Cancer Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney Cancer Treatment Drugs development in United States, Europe and China.
    
    Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.
    Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits.
    In 2017, the global Kidney Cancer Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
    
    The key players covered in this study
        Amgen/Allergan
        Argos Therapeutics
        AstraZeneca
        Aveo Pharmaceuticals
        Bayer
        Exelixis
        Incyte
        Merck
        Roche
        Pfizer
        Bristol-Myers Squibb
        Eisai
        Prometheus Labs
        Novartis
    
    Market segment by Type, the product can be split into
        Angiogenesis Inhibitors
        mTOR Inhibitors
        Monoclonal Antibodies
        Cytokine Immunotherapy (IL-2)
    
    Market segment by Application, split into
        Hospitals
        Research Institutes
        Diagnostic Centers
        Others
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Kidney Cancer Treatment Drugs status, future forecast, growth opportunity, key market and key players.
        To present the Kidney Cancer Treatment Drugs development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Kidney Cancer Treatment Drugs are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Type (2013-2025)
            1.4.2 Angiogenesis Inhibitors
            1.4.3 mTOR Inhibitors
            1.4.4 Monoclonal Antibodies
            1.4.5 Cytokine Immunotherapy (IL-2)
        1.5 Market by Application
            1.5.1 Global Kidney Cancer Treatment Drugs Market Share by Application (2013-2025)
            1.5.2 Hospitals
            1.5.3 Research Institutes
            1.5.4 Diagnostic Centers
            1.5.5 Others
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Kidney Cancer Treatment Drugs Market Size
        2.2 Kidney Cancer Treatment Drugs Growth Trends by Regions
            2.2.1 Kidney Cancer Treatment Drugs Market Size by Regions (2013-2025)
            2.2.2 Kidney Cancer Treatment Drugs Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Kidney Cancer Treatment Drugs Market Size by Manufacturers
            3.1.1 Global Kidney Cancer Treatment Drugs Revenue by Manufacturers (2013-2018)
            3.1.2 Global Kidney Cancer Treatment Drugs Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Kidney Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
        3.2 Kidney Cancer Treatment Drugs Key Players Head office and Area Served
        3.3 Key Players Kidney Cancer Treatment Drugs Product/Solution/Service
        3.4 Date of Enter into Kidney Cancer Treatment Drugs Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Kidney Cancer Treatment Drugs Market Size by Type (2013-2018)
        4.2 Global Kidney Cancer Treatment Drugs Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Kidney Cancer Treatment Drugs Market Size (2013-2018)
        5.2 Kidney Cancer Treatment Drugs Key Players in United States
        5.3 United States Kidney Cancer Treatment Drugs Market Size by Type
        5.4 United States Kidney Cancer Treatment Drugs Market Size by Application
    
    6 Europe
        6.1 Europe Kidney Cancer Treatment Drugs Market Size (2013-2018)
        6.2 Kidney Cancer Treatment Drugs Key Players in Europe
        6.3 Europe Kidney Cancer Treatment Drugs Market Size by Type
        6.4 Europe Kidney Cancer Treatment Drugs Market Size by Application
    
    7 China
        7.1 China Kidney Cancer Treatment Drugs Market Size (2013-2018)
        7.2 Kidney Cancer Treatment Drugs Key Players in China
        7.3 China Kidney Cancer Treatment Drugs Market Size by Type
        7.4 China Kidney Cancer Treatment Drugs Market Size by Application
    
    8 Japan
        8.1 Japan Kidney Cancer Treatment Drugs Market Size (2013-2018)
        8.2 Kidney Cancer Treatment Drugs Key Players in Japan
        8.3 Japan Kidney Cancer Treatment Drugs Market Size by Type
        8.4 Japan Kidney Cancer Treatment Drugs Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Kidney Cancer Treatment Drugs Market Size (2013-2018)
        9.2 Kidney Cancer Treatment Drugs Key Players in Southeast Asia
        9.3 Southeast Asia Kidney Cancer Treatment Drugs Market Size by Type
        9.4 Southeast Asia Kidney Cancer Treatment Drugs Market Size by Application
    
    10 India
        10.1 India Kidney Cancer Treatment Drugs Market Size (2013-2018)
        10.2 Kidney Cancer Treatment Drugs Key Players in India
        10.3 India Kidney Cancer Treatment Drugs Market Size by Type
        10.4 India Kidney Cancer Treatment Drugs Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Kidney Cancer Treatment Drugs Market Size (2013-2018)
        11.2 Kidney Cancer Treatment Drugs Key Players in Central & South America
        11.3 Central & South America Kidney Cancer Treatment Drugs Market Size by Type
        11.4 Central & South America Kidney Cancer Treatment Drugs Market Size by Application
    
    12 International Players Profiles
        12.1 Amgen/Allergan
            12.1.1 Amgen/Allergan Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Kidney Cancer Treatment Drugs Introduction
            12.1.4 Amgen/Allergan Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.1.5 Amgen/Allergan Recent Development
        12.2 Argos Therapeutics
            12.2.1 Argos Therapeutics Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Kidney Cancer Treatment Drugs Introduction
            12.2.4 Argos Therapeutics Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.2.5 Argos Therapeutics Recent Development
        12.3 AstraZeneca
            12.3.1 AstraZeneca Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Kidney Cancer Treatment Drugs Introduction
            12.3.4 AstraZeneca Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.3.5 AstraZeneca Recent Development
        12.4 Aveo Pharmaceuticals
            12.4.1 Aveo Pharmaceuticals Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Kidney Cancer Treatment Drugs Introduction
            12.4.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.4.5 Aveo Pharmaceuticals Recent Development
        12.5 Bayer
            12.5.1 Bayer Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Kidney Cancer Treatment Drugs Introduction
            12.5.4 Bayer Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.5.5 Bayer Recent Development
        12.6 Exelixis
            12.6.1 Exelixis Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Kidney Cancer Treatment Drugs Introduction
            12.6.4 Exelixis Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.6.5 Exelixis Recent Development
        12.7 Incyte
            12.7.1 Incyte Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Kidney Cancer Treatment Drugs Introduction
            12.7.4 Incyte Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.7.5 Incyte Recent Development
        12.8 Merck
            12.8.1 Merck Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Kidney Cancer Treatment Drugs Introduction
            12.8.4 Merck Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.8.5 Merck Recent Development
        12.9 Roche
            12.9.1 Roche Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Kidney Cancer Treatment Drugs Introduction
            12.9.4 Roche Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.9.5 Roche Recent Development
        12.10 Pfizer
            12.10.1 Pfizer Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Kidney Cancer Treatment Drugs Introduction
            12.10.4 Pfizer Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)
            12.10.5 Pfizer Recent Development
        12.11 Bristol-Myers Squibb
        12.12 Eisai
        12.13 Prometheus Labs
        12.14 Novartis
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Kidney Cancer Treatment Drugs Key Market Segments
        Table Key Players Kidney Cancer Treatment Drugs Covered
        Table Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Kidney Cancer Treatment Drugs Market Size Market Share by Type 2013-2025
        Figure Angiogenesis Inhibitors Figures
        Table Key Players of Angiogenesis Inhibitors
        Figure mTOR Inhibitors Figures
        Table Key Players of mTOR Inhibitors
        Figure Monoclonal Antibodies Figures
        Table Key Players of Monoclonal Antibodies
        Figure Cytokine Immunotherapy (IL-2) Figures
        Table Key Players of Cytokine Immunotherapy (IL-2)
        Table Global Kidney Cancer Treatment Drugs Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospitals Case Studies
        Figure Research Institutes Case Studies
        Figure Diagnostic Centers Case Studies
        Figure Others Case Studies
        Figure Kidney Cancer Treatment Drugs Report Years Considered
        Table Global Kidney Cancer Treatment Drugs Market Size 2013-2025 (Million US$)
        Figure Global Kidney Cancer Treatment Drugs Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Kidney Cancer Treatment Drugs Market Size by Regions 2013-2025 (Million US$)
        Table Global Kidney Cancer Treatment Drugs Market Size by Regions 2013-2018 (Million US$)
        Table Global Kidney Cancer Treatment Drugs Market Share by Regions 2013-2018
        Figure Global Kidney Cancer Treatment Drugs Market Share by Regions 2013-2018
        Figure Global Kidney Cancer Treatment Drugs Market Share by Regions 2018
        Table Market Top Trends
        Table Global Kidney Cancer Treatment Drugs Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Kidney Cancer Treatment Drugs Market Share by Manufacturers (2013-2018)
        Figure Global Kidney Cancer Treatment Drugs Market Share by Manufacturers in 2018
        Table Global Kidney Cancer Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Kidney Cancer Treatment Drugs Product/Solution/Service
        Table Date of Enter into Kidney Cancer Treatment Drugs Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Kidney Cancer Treatment Drugs Market Size by Type (2013-2018) (Million US$)
        Table Global Kidney Cancer Treatment Drugs Market Size Share by Type (2013-2018)
        Figure Global Kidney Cancer Treatment Drugs Market Size Market Share by Type (2013-2018)
        Table Global Kidney Cancer Treatment Drugs Market Size by Application (2013-2018) (Million US$)
        Table Global Kidney Cancer Treatment Drugs Market Size Share by Application (2013-2018)
        Figure Global Kidney Cancer Treatment Drugs Market Size Market Share by Application (2013-2018)
        Figure Global Kidney Cancer Treatment Drugs Revenue Market Share by Application in 2017
        Figure United States Kidney Cancer Treatment Drugs Market Size 2013-2018 (Million US$)
        Table United States Key Players Kidney Cancer Treatment Drugs Revenue (2017-2018) (Million US$)
        Table United States Key Players Kidney Cancer Treatment Drugs Market Share (2017-2018)
        Table United States Kidney Cancer Treatment Drugs Market Size by Type (2013-2018) (Million US$)
        Table United States Kidney Cancer Treatment Drugs Market Share by Type (2013-2018)
        Table United States Kidney Cancer Treatment Drugs Market Size by Application (2013-2018) (Million US$)
        Table United States Kidney Cancer Treatment Drugs Market Share by Application (2013-2018)
        Figure Europe Kidney Cancer Treatment Drugs Market Size 2013-2018 (Million US$)
        Table Europe Key Players Kidney Cancer Treatment Drugs Revenue (2017-2018) (Million US$)
        Table Europe Key Players Kidney Cancer Treatment Drugs Market Share (2017-2018)
        Table Europe Kidney Cancer Treatment Drugs Market Size by Type (2013-2018) (Million US$)
        Table Europe Kidney Cancer Treatment Drugs Market Share by Type (2013-2018)
        Table Europe Kidney Cancer Treatment Drugs Market Size by Application (2013-2018) (Million US$)
        Table Europe Kidney Cancer Treatment Drugs Market Share by Application (2013-2018)
        Figure China Kidney Cancer Treatment Drugs Market Size 2013-2018 (Million US$)
        Table China Key Players Kidney Cancer Treatment Drugs Revenue (2017-2018) (Million US$)
        Table China Key Players Kidney Cancer Treatment Drugs Market Share (2017-2018)
        Table China Kidney Cancer Treatment Drugs Market Size by Type (2013-2018) (Million US$)
        Table China Kidney Cancer Treatment Drugs Market Share by Type (2013-2018)
        Table China Kidney Cancer Treatment Drugs Market Size by Application (2013-2018) (Million US$)
        Table China Kidney Cancer Treatment Drugs Market Share by Application (2013-2018)
        Figure Japan Kidney Cancer Treatment Drugs Market Size 2013-2018 (Million US$)
        Table Japan Key Players Kidney Cancer Treatment Drugs Revenue (2017-2018) (Million US$)
        Table Japan Key Players Kidney Cancer Treatment Drugs Market Share (2017-2018)
        Table Japan Kidney Cancer Treatment Drugs Market Size by Type (2013-2018) (Million US$)
        Table Japan Kidney Cancer Treatment Drugs Market Share by Type (2013-2018)
        Table Japan Kidney Cancer Treatment Drugs Market Size by Application (2013-2018) (Million US$)
        Table Japan Kidney Cancer Treatment Drugs Market Share by Application (2013-2018)
        Figure Southeast Asia Kidney Cancer Treatment Drugs Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Kidney Cancer Treatment Drugs Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Kidney Cancer Treatment Drugs Market Share (2017-2018)
        Table Southeast Asia Kidney Cancer Treatment Drugs Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Kidney Cancer Treatment Drugs Market Share by Type (2013-2018)
        Table Southeast Asia Kidney Cancer Treatment Drugs Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Kidney Cancer Treatment Drugs Market Share by Application (2013-2018)
        Figure India Kidney Cancer Treatment Drugs Market Size 2013-2018 (Million US$)
        Table India Key Players Kidney Cancer Treatment Drugs Revenue (2017-2018) (Million US$)
        Table India Key Players Kidney Cancer Treatment Drugs Market Share (2017-2018)
        Table India Kidney Cancer Treatment Drugs Market Size by Type (2013-2018) (Million US$)
        Table India Kidney Cancer Treatment Drugs Market Share by Type (2013-2018)
        Table India Kidney Cancer Treatment Drugs Market Size by Application (2013-2018) (Million US$)
        Table India Kidney Cancer Treatment Drugs Market Share by Application (2013-2018)
        Figure Central & South America Kidney Cancer Treatment Drugs Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Kidney Cancer Treatment Drugs Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Kidney Cancer Treatment Drugs Market Share (2017-2018)
        Table Central & South America Kidney Cancer Treatment Drugs Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Kidney Cancer Treatment Drugs Market Share by Type (2013-2018)
        Table Central & South America Kidney Cancer Treatment Drugs Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Kidney Cancer Treatment Drugs Market Share by Application (2013-2018)
        Table Amgen/Allergan Company Details
        Table Amgen/Allergan Revenue in Kidney Cancer Treatment Drugs Business (2013-2018) (Million US$)
        Figure Amgen/Allergan Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Amgen/Allergan Recent Development
        Table Argos Therapeutics Company Details
        Table Argos Therapeutics Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure Argos Therapeutics Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Argos Therapeutics Recent Development
        Table AstraZeneca Company Details
        Table AstraZeneca Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure AstraZeneca Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table AstraZeneca Recent Development
        Table Aveo Pharmaceuticals Company Details
        Table Aveo Pharmaceuticals Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Aveo Pharmaceuticals Recent Development
        Table Bayer Company Details
        Table Bayer Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure Bayer Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Bayer Recent Development
        Table Exelixis Company Details
        Table Exelixis Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure Exelixis Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Exelixis Recent Development
        Table Incyte Company Details
        Table Incyte Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure Incyte Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Incyte Recent Development
        Table Merck Company Details
        Table Merck Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure Merck Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Merck Recent Development
        Table Roche Company Details
        Table Roche Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure Roche Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Roche Recent Development
        Table Pfizer Company Details
        Table Pfizer Revenue in Kidney Cancer Treatment Drugs Business (2013-2018)(Million US$)
        Figure Pfizer Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2013-2018)
        Table Pfizer Recent Development
        Table Bristol-Myers Squibb Company Details
        Table Eisai Company Details
        Table Prometheus Labs Company Details
        Table Novartis Company Details
        Table Global Kidney Cancer Treatment Drugs Market Size by Regions (Million US$) 2018-2025
        Figure Global Kidney Cancer Treatment Drugs Market Size Share by Regions (2018-2025)
        Figure Global Kidney Cancer Treatment Drugs Market Size Share by Regions in 2025
        Figure United States Kidney Cancer Treatment Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Kidney Cancer Treatment Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure China Kidney Cancer Treatment Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Kidney Cancer Treatment Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Kidney Cancer Treatment Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure India Kidney Cancer Treatment Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Kidney Cancer Treatment Drugs Market Size Forecast (2018-2025)(Million USD)
        Table Global Kidney Cancer Treatment Drugs Market Size by Product (2018-2025) (Million US$)
        Figure Global Kidney Cancer Treatment Drugs Market Size by Product (2018-2025)
        Figure Global Kidney Cancer Treatment Drugs Market Size by Product in 2025
        Table Global Kidney Cancer Treatment Drugs Market Size by Application (2018-2025) (Million US$)
        Figure Global Kidney Cancer Treatment Drugs Market Size by Application (2018-2025)
        Figure Global Kidney Cancer Treatment Drugs Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources